Liping Liu is the founder of HighTide Therapeutics. HighTide Therapeutics has raised $167M in total funding. Latest round: Series C. Based in Shenzhen, China.
Liping Liu is the Founder and CEO of HighTide Therapeutics, a clinical-stage biopharmaceutical company focused on developing multifunctional therapies for metabolic and digestive diseases. She was recognized as an EY Entrepreneurial Winning Women™ Asia-Pacific Class of 2023 honoree.
Full founder directory · Investor directory · Company funding database · Fundraising library